Facebook
Twitter
Telegram
Report an ErrorArmata Pharmaceuticals Financial Statements 2011-2024 | ARMP
Annual Financial Statements Armata Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
133 M | 65.2 M | 117 M | 90.3 M | 24.8 M | 4.75 M | 7.73 M | 4.53 M | 16.2 M | 33.7 M | 63.8 M | 6.72 M | 9.8 M |
Shares |
36.1 M | 34.3 M | 24.1 M | 18.4 M | 6.69 M | 1.36 M | 456 K | 70.3 K | 38.7 K | 26.8 K | 14.5 K | 6.86 K | 10 K |
Historical Prices |
3.69 | 1.9 | 4.87 | 4.91 | 3.98 | 3.64 | 15.8 | 63 | 420 | 1.26 K | 4.62 K | 980 | 980 |
Net Income |
-69 M | -36.9 M | -23.2 M | -22.2 M | -19.5 M | -12.1 M | -12.8 M | -18.8 M | -516 K | 23.1 M | -58.4 M | -1.11 M | -3.79 M |
Revenue |
- | - | - | 823 K | - | - | 115 K | 260 K | 475 K | 409 K | 325 K | 664 K | 120 K |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | 823 K | - | - | - | - | 475 K | 409 K | 325 K | 664 K | - |
Operating Income |
-40.9 M | -36.9 M | -23.8 M | -21.6 M | -19.8 M | -17.7 M | -16.2 M | -23.4 M | -10.2 M | -14.1 M | -12.4 M | - | - |
Interest Expense |
-28.2 M | 29 K | 64 K | 628 K | 931 K | 1.01 M | 2.02 M | 6 K | 9.64 M | - | 233 K | - | - |
EBITDA |
-39.9 M | -36.1 M | -22.7 M | -20.5 M | -17.7 M | -10.2 M | -9.98 M | -13.5 M | -9.9 M | -14 M | -14.9 M | -3.93 M | -3.83 M |
Operating Expenses |
45.4 M | 42.5 M | 28.3 M | 22.4 M | 19.1 M | 10.6 M | 10.5 M | 14.1 M | 10.7 M | 14.5 M | 15.3 M | 4.69 M | 4.03 M |
General and Administrative Expenses |
11.6 M | 7.44 M | 8.28 M | 7.97 M | 9.26 M | 5.7 M | - | 8.41 M | 6.71 M | 8.71 M | 8.81 M | 3.21 M | 3.33 M |
All numbers in USD currency
Quarterly Income Statement Armata Pharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
36.1 M | 36.1 M | 36 M | 36.1 M | 36 M | 36 M | 29 M | 27.1 M | 24.8 M | 24.8 M | 20.5 M | 18.7 M | 18.4 M | 18.3 M | 10.5 M | 9.92 M | 9.55 M | 7.51 M | 32.4 M | 5.07 M | 4.65 M | 4.65 M | 13.3 M | 9.5 M | 8.87 M | 5.35 M | 1.68 M | 1.65 M | 1.11 M | 874 K | 5.88 M | 5.88 M | 5.81 M | 5.67 M | 4.25 M | 3.98 M | 3.74 M | 3.67 M | 183 M | 183 M | 99.2 M | 90.6 M | 101 M | - | - | - | - | - | - | - | - |
Net Income |
-31.2 M | -3.55 M | -14.5 M | - | -8.61 M | -9.22 M | -8.77 M | - | -5.42 M | -6.19 M | -5.5 M | - | -5.77 M | -4.71 M | -5.08 M | - | -6.96 M | -4.2 M | -3.74 M | - | -2.77 M | -3.17 M | -3.13 M | - | -779 K | -6.46 M | -3.25 M | -9.5 M | -2.38 M | -3.85 M | -3.11 M | -2.23 M | -516 K | -516 K | -516 K | -664 K | 23.1 M | 23.1 M | 23.1 M | - | -64.6 M | -64.6 M | -64.6 M | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | 31 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-10.3 M | -9.63 M | -11.3 M | - | -8.62 M | -9.22 M | -8.78 M | - | -6.14 M | -6.2 M | -5.44 M | - | -5.62 M | -4.59 M | -4.92 M | - | -6.78 M | -5.16 M | -3.44 M | - | -2.43 M | -2.84 M | -3.06 M | - | -746 K | -9.69 M | -3.36 M | -11.9 M | -3.41 M | -3.59 M | -4.52 M | -2.94 M | -2.43 M | -2.59 M | -2.27 M | -2.6 M | -5.23 M | -3.75 M | -2.53 M | - | -2.34 M | -6.12 M | -12.4 M | - | - | - | - | - | - | - | - |
Interest Expense |
1.18 M | 6.08 M | -3.14 M | - | 9 K | 5 K | 1 K | - | 2 K | 62 K | 62 K | - | 150 K | 142 K | 159 K | - | 190 K | 230 K | 306 K | - | 307 K | 281 K | -79 K | - | -33 K | 1.92 M | 7 K | 1.81 M | 1.03 M | -262 K | 1.41 M | 636 K | 7.87 M | 13.4 M | -12.2 M | - | - | - | - | - | 9 K | 128 K | 233 K | - | - | - | - | - | - | - | - |
EBITDA |
-10.1 M | -9.43 M | -11.1 M | - | -8.42 M | -9.02 M | -8.55 M | - | -5.84 M | -5.9 M | -5.15 M | - | -5.32 M | -4.29 M | -4.63 M | - | -6.38 M | -4.82 M | -3.09 M | - | -2.09 M | -2.44 M | -2.97 M | - | -491 K | -9.52 M | -3.27 M | -11.9 M | -3.16 M | -3.43 M | -4.44 M | -2.94 M | -2.21 M | -2.48 M | -2.21 M | -2.6 M | -5.17 M | -3.66 M | -2.52 M | - | -2.28 M | -6.08 M | -12.3 M | - | - | - | - | - | - | - | - |
Operating Expenses |
11.6 M | 10.6 M | 12.1 M | - | 9.96 M | 11.1 M | 10 M | - | 7.39 M | 7.36 M | 6.5 M | - | 5.91 M | 4.62 M | 4.92 M | - | 6.78 M | 5.16 M | 3.61 M | - | 2.43 M | 2.84 M | 3.06 M | - | 784 K | 9.71 M | 3.39 M | 11.9 M | 3.44 M | 3.69 M | 4.62 M | 3.07 M | 2.57 M | 2.69 M | 2.37 M | 2.7 M | 5.33 M | 3.85 M | 2.64 M | - | 2.34 M | 6.44 M | 12.5 M | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
3.58 M | 2.35 M | 2.54 M | - | 1.56 M | 2.08 M | 1.98 M | - | 1.77 M | 2.14 M | 2.15 M | - | 1.84 M | 1.97 M | 2.17 M | - | 3.76 M | 2.08 M | 1.38 M | - | 514 K | 557 K | 1.59 M | - | 1.61 M | 2.78 M | 1.9 M | - | 1.78 M | 2.45 M | 2.64 M | - | 1.84 M | 1.62 M | 1.4 M | - | 1.7 M | 1.96 M | 1.63 M | - | 1.22 M | 2.84 M | 6 M | - | - | - | - | - | - | - | - |
All numbers in USD currency